期刊文献+

舒芬太尼复合氯诺昔康在老年人胸部手术后静脉自控镇痛的应用

Application of sufentanil combined with lornoxicam in the elderly patients controlled intravenous analgesia after thoraces surgery
下载PDF
导出
摘要 目的观察舒芬太尼复合氯诺昔康在老年人胸部手术后静脉自控镇痛的应用效果。方法60例老年人普胸手术后行静脉自控镇痛,随机分为两组:A组(舒芬太尼1μg/ml加入0.9%生理盐水稀释到100ml,PCIA)。B组(舒芬太尼0.5μg/ml联合氯诺昔康0.32mg/ml加入0.9%生理盐水稀释到100ml,PCIA)。观察术后4、8、16、24、48h的镇痛效果、镇静评分及不良反应。结果两组镇痛效果比较差异无统计学意义(P>0.05)。镇静效果:A组镇静较强,与B组比较差异有统计学意义(P<0.05)。不良反应:两组恶心、呕吐、皮肤瘙痒发生率无统计学意义(P>0.05),两组均无呼吸抑制及胃出血发生。结论老年人普胸手术后行舒芬太尼复合氯诺昔康静脉自控镇痛效果好,不良反应少。 Objective To observe the effects of sufentanil combined with lomoxicam in the elderly patients controlled intravenous analgesia (PCIA) after thoraces surgery. Methods Sixty elderly patients scheduled for the thoraces sugery were divided randomly into two groups:sufentanil 1ug/ml in A group( n = 30) and sufentanil 0. 5 μg/ml plus lornoxieam 0. 32 mg/ml in B group (n =30). Each drug was diluted to 100 ml and infused by an pump at a rate of 2 ml/h. The sedative scores, visual analogue scales, and side effects were recorded at 4,8,16,24,48 hour after operation. Results There were no significant differences in the potency of analgesia between the two groups. The sedative scores of group A was more obviously than group B. The incidence rate of the side effects was same in group A and B, such as nausea, vomiting, swirl, and itch of skin. There were no respiratory depression and gastrorrhagia in the two goups. Conclusion PCIA with sufentanil combined with lomoxicam was safe and effective for the elderly patients after thoraces surgery.
出处 《中国实用医药》 2009年第9期15-16,共2页 China Practical Medicine
关键词 舒芬太尼 氯诺昔康 老年 术后镇痛 Sufentanyl Lomoxicam Elderly Postoperative analgesia
  • 相关文献

参考文献12

  • 1Craig DB.Postoperative recovery of pulmonary function.Anesth Analg,1981,60:46-52.
  • 2Russell GB,Graybeal JM.Hypoxemic episodes of patients in a postanest hesia care unit.Chest,1993,104:899-903.
  • 3肖旺频,方芬,周礼湘,陆琪宝,赵慧琴.开胸食管癌手术后病人自控硬膜外镇痛对内分泌和呼吸功能的影响[J].中华麻醉学杂志,1999,19(5):273-275. 被引量:41
  • 4Wamer Do.Dreventing postoperative pulmonary complications.Anesthesiology,2000,92:1467-1472.
  • 5Power I,Barratt S.Analgesic agents for the postoperative period:nonopioids.Surg Clin North Am,1999,79:275-295.
  • 6Tong D,Chung F.Postoperative pain control in ambulatory surgery.Surg Clin North Am,1999,79:401-403.
  • 7Lipsky LP,Abramson SB,Crofford L,et al.The classification of cyclooxygenase inhibitors.J Rheumatol,1998,25:2298-2303.
  • 8Prakanrattana U,Sukompong S.Comparison of sufentanil and fentanyl for surgical repair of congenital cardiac defects.J Med Asso Thai,2002,85:807-814.
  • 9Bailey PL,Streisand JB,East KA,et al.Differences in magnitude and duration of opioid-induced respiratory depression and analgesia with fentanyl and sufentanil.Anesth Analg,1990,70:8-15.
  • 10Kullich W,Klein G.Influence of the nonsteroidal anti-inflammatory drug lornoxicam iv on the secretion of the endogenous opiate peptides dynorphin and edlorphin.Aktuel Rheumatol,1992,17:128-132.

二级参考文献3

共引文献77

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部